The Trump administration is set to launch TrumpRx, a website to help patients buy prescription drugs directly from manufacturers at discounted rates. White House press secretary Karoline Leavitt announced Thursday's expected unveiling in a social media post. The website is not a purchasing platform but directs users to drugmakers' own sites. President Trump first mentioned TrumpRx in September, highlighting deals with pharmaceutical companies to lower drug prices. The website's release faced delays, but it now showcases efforts to reduce costs through agreements with major companies like Pfizer and AstraZeneca. However, the actual savings for consumers remain unclear.
Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices. But California won't be the only state making lower-cost insulin available. The nonprofit Civica says Thursday it will also distribute its economical diabetes medication to pharmacies nationwide. Starting in the new year, insulin pens will be available in California under the CalRx label for $11 per pen, or a maximum of $55 for a five-pack.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many. Coverage also continues to shift or restrict how patients get prescriptions. Doctors say the patchy coverage and costs force them to get creative in treating patients. But there's hope that prices for the injectable drugs may fall more in the future, especially once pill versions enter the market.
IV therapy clinics are springing up around the country, touting quick ways to recover from a hangover or a hard workout. But doctors and regulators preach caution before plunging into a visit. The service has been on a growth spurt since the COVID-19 pandemic, offering drips that also aim to boost energy levels or immune systems or deal with things like joint pain. Regulators worry about who delivers the treatments, the source of any pharmaceuticals used and how the services are provided. Customers should come prepared to ask questions before they get connected.
By JONEL ALECCIA and MATTHEW PERRONE Associated Press
U.S. health officials plan to phase out eight petroleum-based colors from the nation's food supply. The move would trigger an overhaul of scores of products on U.S. grocery store shelves. Details of the plan were expected to be announced Tuesday afternoon by Health Secretary Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Marty Makary. The FDA currently allows 36 color additives, including eight synthetic dyes. In January, the agency banned the color known as Red 3. Food producers would likely replace the dyes with natural substitutes.
Taxpayers are expected to save billions after the Biden administration inked deals with pharmaceutical companies to knock down the list prices for 10 of Medicare's costliest drugs. But how much older Americans can expect to save when they fill a prescription at their local pharmacy remains unclear, since the list cost isn't the final price people pay. The list prices of drugs including blood thinners, diabetes drugs and blood cancer medications will be reduced by hundreds — in some cases, thousands — of dollars for 30-day supplies. White House officials say they expect taxpayers to save $6 billion and older adults could save about $1.5 billion in total. The new prices won't go into effect until 2026.
